Taysha Gene Therapies Balance Sheet (2022-2025) | TSHA

1Y3Y5Y7Y10YAll
Download Data
Balance Sheet Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Accumulated Depreciation 0.75M1.02M1.29M1.64M1.97M2.31M2.64M2.98M3.31M3.63M3.91M3.58M3.82M4.10M4.38M
Assets
Current Assets
Cash & Equivalents 99.27M68.88M36.94M87.88M63.42M45.08M164.28M143.94M123.98M172.74M157.69M139.04M116.60M312.80M297.34M
Receivables - Other 2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M2.60M
Prepaid Assets 10.26M10.60M8.70M8.54M8.93M9.03M5.53M3.48M4.17M3.28M3.42M2.65M3.67M3.05M2.16M
Current Assets 106.89M76.83M43.00M96.42M72.36M54.12M171.81M149.87M130.60M178.47M161.56M142.13M120.71M316.26M299.95M
Non-Current Assets
Construction in Progress 50.40M56.30M59.00M
Property, Plant & Equipment (Net) 55.12M61.01M63.95M14.96M14.64M14.14M11.17M10.83M10.69M10.51M7.61M7.49M7.24M6.96M6.80M
Other Non-Current Assets 2.64M2.64M2.64M2.64M2.64M2.64M2.64M2.60M2.60M2.60M2.60M2.15M2.60M2.60M2.60M
Non-Current Assets 59.09M65.50M68.47M29.86M29.24M27.43M23.96M22.86M22.40M21.92M18.66M18.23M17.65M17.07M16.60M
Assets 165.98M142.33M111.47M126.28M101.60M81.54M195.77M172.73M153.00M200.39M180.22M160.36M138.36M333.33M316.55M
Liabilities
Current Liabilities
Accounts Payables 22.00M23.97M15.25M10.95M9.00M10.77M7.52M6.37M10.38M8.72M4.93M3.59M4.33M7.71M5.44M
Payables 22.00M23.97M15.25M10.95M9.00M10.77M7.52M6.37M10.38M8.72M4.93M3.59M4.33M7.71M5.44M
Accumulated Expenses 26.62M18.99M17.89M18.29M16.60M19.63M13.64M12.28M13.56M11.88M12.61M12.86M10.76M12.15M17.71M
Other Accumulated Expenses 1.59M1.48M1.58M0.65M0.69M0.68M0.68M0.72M0.78M0.78M0.88M0.75M0.81M0.80M0.75M
Short term Debt 140.53M
Current Leases 1.52M1.75M1.64M1.54M1.65M1.70M1.75M1.81M1.88M1.81M1.74M1.67M
Current Deferred Revenue 33.56M28.90M20.24M18.80M18.11M14.70M13.60M11.80M9.80M7.50M5.50M5.50M
Total Current Liabilities 48.62M42.95M33.14M62.79M54.45M50.64M180.45M36.76M38.64M34.18M29.34M26.23M22.56M25.35M28.63M
Non-Current Liabilities
Non-Current Debt 37.39M37.58M37.77M37.97M38.16M38.35M38.55M40.51M40.51M37.84M42.97M43.94M42.45M41.05M50.85M
Non-Current Deffered Revenue 6.21M3.00M
Operating Leases 20.44M19.93M19.53M19.10M18.95M18.50M18.13M17.75M17.36M17.09M16.81M16.51M
Other Non-Current Liabilities 3.50M3.48M3.93M4.13M4.00M3.92M3.83M1.58M42.13M39.23M44.37M1.31M1.20M1.40M1.58M
Total Non-Current Liabilities 111.75M106.14M96.41M121.20M112.54M114.73M241.05M96.22M57.02M52.29M47.05M87.53M82.10M83.21M95.99M
Total Liabilities 115.25M109.62M100.34M125.33M116.55M118.66M244.88M97.79M99.15M91.53M91.42M88.84M83.30M84.60M97.56M
Shareholder's Equity
Total Debt 37.39M37.58M37.77M37.97M38.16M38.35M179.08M40.51M40.51M37.84M42.97M43.94M42.45M41.05M50.85M
Common Equity 50.74M32.51M10.70M0.95M-14.95M-37.11M-49.11M74.94M53.85M108.87M88.80M71.53M55.06M248.73M218.99M
Shareholder's Equity 50.74M32.51M10.70M0.95M-14.95M-37.11M-49.11M74.94M53.85M108.87M88.80M71.53M55.06M248.73M218.99M
Liabilities and Shareholders Equity 165.98M142.33M111.47M126.28M101.60M81.54M195.77M172.73M153.00M200.39M180.22M160.36M138.36M333.33M316.55M
Retained Earnings -285.80M-319.63M-345.94M-401.44M-419.10M-443.70M-560.75M-513.01M-537.10M-558.00M-583.52M-602.30M-623.83M-650.72M-683.45M
Treasury Shares 1.89M1.34M1.26M1.26M0.68M0.46M0.38M0.38M4.66M4.63M4.55M4.55M6.24M6.27M6.27M